SCHEMBL5547848

SCHEMBL5547848

O=[N+]([O-])C1C=CC2=CCNCCC2=C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.34
HTR6 P50406 2/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 6/20 0.33
HRH3 Q9Y5N1 1/20 0.33
QDPR P09417 1/20 0.33
GABRP O00591 1/20 0.31
GABRD O14764 1/20 0.31
GABRA1 P14867 1/20 0.31
TSHR P16473 1/20 0.31
GABRB1 P18505 1/20 0.31
GABRG2 P18507 1/20 0.31
GABRR1 P24046 1/20 0.31
GABRB3 P28472 1/20 0.31
GABRA5 P31644 1/20 0.31
GABRA3 P34903 1/20 0.31
GABRA2 P47869 1/20 0.31
GABRB2 P47870 1/20 0.31
GABRA4 P48169 1/20 0.31
GABRE P78334 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5548707 0.63 SIGMAR1 (0.42) SIGMAR1HTR2CHRH3QDPRGABRP
SCHEMBL1671185 0.62
SCHEMBL4789631 0.61 HTR2C (0.56) SIGMAR1HTR6HTR2AHTR2CQDPR
Hydrochloric Acid SCHEMBL9958496 0.60 HTR2C (0.57) SIGMAR1HTR6HTR2AHTR2CQDPR
SCHEMBL23735110 0.59 SIGMAR1 (0.50) SIGMAR1HTR6HTR2AHTR2CHRH3
Hydrochloric Acid SCHEMBL1513499 0.58 HTR2C (0.53) SIGMAR1HTR6HTR2AHTR2CQDPR
SCHEMBL4790049 0.58 HTR2C (0.53) SIGMAR1HTR6HTR2AHTR2CQDPR
SCHEMBL29101210 0.58 HTR6 (0.39) SIGMAR1HTR6HTR2AHTR2CHRH3
SCHEMBL4789895 0.57 HTR2C (0.57) SIGMAR1HTR6HTR2AHTR2CQDPR
SCHEMBL22265048 0.55

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1835934-A2 ENZYME MODULATORS AND TREATMENTS Deciphera Pharmaceuticals, LLC (US) 2007-09-26 EP disclosed
WO-2006071940-A2 ENZYME MODULATORS AND TREATMENTS DECIPHERA PHARMACEUTICALS, LLC (US) 2006-07-06 WO disclosed